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Abstract
Background: Chronic Obstructive Pulmonary Disease (COPD) is a prevalent debilitating long term condition. It is
the second most common cause of emergency admission to hospital in the UK and remains one of the most
costly conditions to treat through acute care.
Tele-health monitoring offers potential to reduce the rates of re-hospitalisation and emergency department visits
and improve quality of life for people with COPD. However, the current evidence base to support technology
adoption and implementation is limited and the resource implications for implementing tele-health in practice can
be very high. This trial will employ tele-health monitoring in a preventative capacity for patients diagnosed with
early stage COPD following discharge from hospital to determine whether it reduces their need for additional
health service support or hospital admission and improves their quality of life.
Methods/Design: We describe a pilot study for a two arm, one site randomized controlled trial (RCT) to determine
the effect of tele-health monitoring on self-management, quality of life and patient satisfaction. Sixty patients who
have been discharged from one acute trust with a primary diagnosis of COPD and who have agreed to receive
community clinical support following discharge from acute care will be randomly assigned to one of two groups:
(a) Tele-health supported Community COPD Service; or (b) Usual Care. The tele-health supported service involves
the patient receiving two home visits with a specialist COPD clinician (nurse or physiotherapist) then participating
in daily tele-monitoring over an eight week period. Usual care consists of six home visits to the patient by
specialist COPD clinicians again over eight successive weeks. Health status and quality of life data for all
participants will be measured at baseline, on discharge from the service and at six months post discharge from the
service.
Discussion: The tele-health service under study is a complex service delivered through a collaboration between
local authority and health care partners. The implementation of this service demanded significant changes to
established working patterns and has been a challenging process requiring considerable planning - a challenge
that many providers are likely to face in the future.
Trial registration: Current Controlled Trials ISRCTN68856013.
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Background
COPD
Chronic Obstructive Pulmonary Disease (COPD) is the
fifth biggest killer disease in the UK [1]. It is also the
second most common cause of emergency admission to
hospital and one of the most costly in-patient conditions
[2], accounting for £587 m of the £1.08bn spent on hos-
pital admissions for lung disease by the NHS [3]. The
current prevalence of COPD in the UK is around 1.5%
of the population (approximately 900,000 people), with
the condition now being of equivalent incidence in both
men and women [4]. The National Institute for Health
and Clinical Excellence (NICE) [5] estimates the direct
cost of COPD at more than £982 million per year when
accounting for indirect costs.
Primarily a smoking related disease, COPD is a long
term condition that affects one in six smokers aged over
45 years and is characterized by a chronic, progressive
decline in lung function. In the early stages of the dis-
ease patients are largely free of symptoms, but as the
disease progresses patients may become house-bound,
socially isolated and depressed. Patients with COPD
thus experience poor quality of life with impaired emo-
tional, social and physical functioning [6]. Exacerbations
in symptoms (characterized by increased airway and sys-
temic inflammation and significant deterioration in lung
function) occur with increasing frequency and often
require hospital management.
Care delivery model
There is a clear case for the redesign of NHS services
for patients with chronic diseases. In 2002, a Cochrane
review [5] concluded that a ‘hospital at home’ approach
was a safe and effective option for certain patients with
COPD with this recommendation being included within
subsequent NICE Guidelines. The NHS Modernisation
Agency [7] also proposed that in the future, patients
with chronic diseases should no longer occupy acute
beds, but rather be treated in a community setting, or
supported at home. A key message from the National
COPD Patient survey [8] was the need to prioritise per-
sonalized COPD planning and self management.
Furthermore, in their 2004 annual report [9], the Foun-
dation for Assistive Technology UK (FAST) suggested
that chronic disease services needed to be redesigned
around patients with a focus on prevention, assessment
and self-management.
Tele-health monitoring is defined as the remote
exchange of physiological data between a patient at
home and medical staff to assist in diagnosis and moni-
toring. It includes (amongst other things) a home unit
to measure and monitor temperature, blood pressure or
other vital signs for clinical review at a remote location
(for example, a hospital site) using phone lines or
wireless technology [10]. The use of community based
medical monitoring technology offers real potential for
people with long term conditions in that it removes the
physical location aspect of health care. Consequently it
is believed that effective use of tele-health could lead to
significant cost savings [11].
Research has demonstrated that timely and effective
treatment and support can shorten COPD exacerba-
tions, leading to a reduction in the need for hospital
admission and patient length of stay, resulting in
improved outcomes and quality of life for patients [1]. A
comprehensive systematic literature review on tele-
health for COPD was undertaken by the King’s Fund
Whole System Demonstrator Action Network [12]. Of
the nine COPD studies included in this review, one
small randomized controlled trial and three observa-
tional studies compared home tele-monitoring and five
trials compared telephone support with usual care.
Home tele-monitoring and telephone support were
found to reduce the rates of re-hospitalization and
emergency department visits.
The evidence for community-based tele-health health
services is more limited. We are aware of one RCT cur-
rently in progress which should be reported upon in
2011 [13]. This is investigating the clinical and cost-
effectiveness of using tele-health technology for sup-
ported self-monitoring of patients with COPD. This two
arm trial is comparing tele-health monitoring with stan-
dard care for patients with moderate to severe COPD,
recruited from Lothian general practices (GPs) who
have been admitted to hospital with an exacerbation of
COPD in the previous six months.
No robust studies have been located which examine
the use of tele-health monitoring of people in the earlier
stages of the condition.
Local context
The RCT will take place in a region covered by one
PCT which has a high incidence of COPD which can be
traced to both its coal mining history and the relatively
high levels of smoking by the population [14]. It is
ranked as one of the most deprived local authorities in
the Index of Multiple Deprivation [15]. The high levels
of deprivation are associated with poor diet and other
adverse lifestyle factors, with smoking being one such
factor [16]. The PCT has been recognized as one of the
best in the country at detecting COPD by the Eastern
Region Public Health Observatory and has been placed
in the top 10 for the detection of COPD against all
other Primary Care Trusts in England [17].
New service developments have been put in place in
the location for this research in order to provide optimal
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management for people with COPD following hospital
discharge. A new Community COPD Service was intro-
duced in May 2009, to manage people with early stage
COPD for up to eight weeks following hospital dis-
charge. The remit of the new service is to encourage
self-management by patients including education, medi-
cation management and lifestyle changes, with the aim
of preventing further admissions and improving patient
quality of life. In May 2010, the PCT introduced a tele-
health supported Community COPD Service. Using the
technology, which is personalized to each patient’s con-
dition, patients are enabled to monitor their own signs
and symptoms, with alerts being provided to community
clinicians should any recorded data fall outside expected
parameters or if the patient fails to provide data. Thus,
community clinicians only need to make additional
patient visits to those planned on the care pathway if an
alert is raised. Service commissioners and providers
identified that this was an opportune time to investigate
the impact of tele-health technology compared to tradi-
tional methods of delivering post discharge community
clinical services. Consequently a pragmatic RCT has
been planned with key staff.
Methods/Design
Given the complexity of the care pathway, the newness
of the services and the lack of population-based data on
which to base the sample size calculation, in accordance
with MRC Guidance, a pilot study will be undertaken.
This pilot study will be conducted over a three month
period and will operate as a ‘mini-trial’, testing all ele-
ments of the definitive trial. It will use the research
methodology developed for the definitive trial in terms
of inclusion/exclusion criteria, care pathways, data col-
lection tools and randomisation procedures which are
outlined below.
Design of the Definitive Trial
The definitive study will be a twelve month, single blind,
two arm, randomized trial in one Primary Care Trust
(PCT) in the United Kingdom. The study population will
be patients discharged from acute care diagnosed with
COPD who have agreed to use the Community COPD
Service as part of their post hospital discharge support.
The study will test the following specific hypotheses:
1. Tele-health monitoring will reduce the proportion
of patients with early stage COPD who require
further hospital re-admissions to manage their
COPD for the duration of, and for six months fol-
lowing discharge from the Tele-health-supported
Community COPD Service when compared with
those who received the standard Community COPD
Service; and
2. Tele-health monitoring will improve the quality of
life for patients for the duration of, and for six
months following discharge from the Community
COPD Service when compared to the standard
Community COPD Service.
There are two referral routes into the Community
COPD Service:
1. The acute trust employs two COPD nurses who
may refer people directly to the Community COPD
Service as a supportive early discharge service.
Patients not wishing to use the early discharge ser-
vice will remain under the care of the inpatient
COPD nurses until alternative arrangements have
been made. Alternatively;
2. Any member of the acute trust nursing staff may use
a new telephone referral service for patients with a
diagnosis of COPD, who are being discharged from any
ward in the hospital. The administration team of the
Community COPD Service triage each of these patients
to ensure that they are eligible to utilise the service.
Primary and Secondary Outcome Measures for the
Definitive Trial
Two primary outcomes will be measured:
1. The health service primary outcome will be the
proportion of patients who are re-admitted to hospi-
tal with COPD as the primary or secondary cause of
their admission, either during, or six months follow-
ing their discharge from the Tele-health supported
or standard Community COPD Service. This will be
assessed through analysis of patient-completed self-
reporting diaries, which will be completed both dur-
ing and for six months following the Tele-health
supported or standard Community COPD Service
and analysis of hospital admission data.
2. The patient-centred primary outcome will be
changes in self-reported health status and quality of
life as measured by comparison of the patients’ St.
Georges Respiratory Questionnaire score upon
admission to either the Tele-health supported or
standard Community COPD Service, on discharge
from the service and six months after discharge
from the service.
There are four secondary outcomes:
1. Proportion of patients requiring unscheduled
health care support to manage their COPD (includ-
ing A&E, GP or community nurse visits) either
during or six months following the standard
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Community COPD Service. This will be collected
using a paper format self-reporting diary for the
standard Community COPD Service and via the
monitoring system for the Tele-health supported
service; and analysis of hospital, GP and community
nursing activity data.
2. Cost effectiveness of intervention. Costs and out-
comes will be collected for each individual patient
recruited to the pilot trial. The data to be collected
for cost estimates will focus on usage of emergency
and home-based care by participants. Health related
quality of life will be measured using the EuroQol 5
Dimensions questionnaire (EQ-5D), which can be
combined with mortality data to produce quality
adjusted life years (QALYs). The EQ-5 D is a simple
patient completed questionnaire (typically taking less
than five minutes to complete), and has been incor-
porated into the COPD self-completed patient dia-
ries. To ensure monthly data collection it has been
embedded into the diaries collected during weeks 1
and 5, whilst the patient is enrolled on the Commu-
nity COPD Service (both modalities) and subsequent
diaries completed each month following discharge
from the Community COPD Service.
Data on service usage (for cost analysis) will be
accessed where possible from routine data systems
of acute and primary care providers and the local
authority rather than being reliant upon patient
recall. The pilot trial will enable the researchers to
examine how feasible it is to both access and analyse
this data.
3. Improved self-management of their COPD by the
individual patient. This will be assessed through ana-
lysis of the results obtained from the St. Georges
Respiratory Questionnaire and those from a self-
completed patient satisfaction questionnaire devised
for this study as described below.
4. Satisfaction with technology as part of their Tele-
health supported Community COPD Service. This
will be assessed through analysis of a self-completed
bespoke tele-health service questionnaire to be com-
pleted by patients on the tele-health supported Com-
munity COPD Service during their final discharge
visit (week 8 after leaving hospital) by Community
COPD Service clinical staff.
Design of the Pilot Study
Given the newness of the Community COPD Service,
population-based data upon which to base a sample size
calculation for the definitive trial is not yet available.
The main purpose of the pilot is therefore to obtain the
required data. The PCT Commissioning Directorate for
the involved PCT has identified that approximately 1200
patients per year are discharged from the hospital with a
primary diagnosis of COPD with the intention being
that all of these patients will be offered the standard
Community COPD Service provided they meet the elig-
ibility criteria. A preliminary review of patients accepted
onto the standard Community COPD Service by the
PCT identified that 63% of all patients currently
accepted on the programme would be eligible for the
trial. If correct, this would suggest that 189 patients
would be eligible for randomisation within the pilot
timeframe, assuming that consent is forthcoming.
The pilot will afford the opportunity to audit the
number of patients referred to, and accepted by, the
Community COPD Service, identify the numbers eligible
for the trial, and those who consent. For the purposes of
this pilot study, a conservative view of the PCT estimate
has been taken, resulting in a recruitment target of 60
patients over a three month period.
This pilot will be used to:
1) Obtain data to calculate the sample size for the
definitive trial, including:
• recruitment
• retention and
• adherence rates;
2) Confirm the integrity of the study protocol,
including:
• Inclusion/exclusion criteria;
• Fidelity of the care pathways;
• Installation, recovery, cleaning and re-stocking
of tele-health equipment; and
• Staff training.
3) Confirm the utility of data collection forms and
questionnaires;
4) Confirm the randomization procedure;
5) Confirm recruitment rates and consent
procedures;
6) Confirm the acceptability of the intervention to
the patients; and
7) Confirm the data collected will allow for reporting
upon the identified outcome measures.
Assuming that no issues are identified during the
internal pilot phase and that approval has been received
from the South Yorkshire Research Ethics Committee,
the definitive trial will commence immediately following
from the pilot.
Ethics
A favourable ethical opinion for this research proposal
has been received from the South Yorkshire Research
Ethics Committee (reference: 10/H130/48).
Participants will only be recruited to the trial if they
can provide informed consent. The Department of
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Health [18] state that “for consent to be valid, it must
be given voluntarily by an appropriately informed per-
son who has the capacity to consent to the intervention
in question”. To ensure that this is the case in this
study, the following measures have been implemented.
Mental capacity
The Mental Capacity Act 2005 [19] defines a person
who lacks capacity as “a person who is unable to make
a decision for themselves because of an impairment or
disturbance in the functioning of their mind or brain”.
It goes on to state that “a person must be assumed to
have capacity unless it is established that they lack capa-
city. If there is any doubt, then the healthcare profes-
sional should assess the capacity of the patient to take
the decision in question”. For this study, all patients will
be initially assessed by health care professionals who
will then provide details of potential participants to the
researchers.
Voluntary consent
Department of Health guidance [18] states that for con-
sent to be valid “it must be given voluntarily and freely,
without pressure or undue influence being exerted upon
them”. Every care will be taken to ensure that the
patient is able to give voluntary consent and they will
have the option to deny consent or withdraw from the
research at any time and without providing any reason
or explanation.
Sufficient information
Department of Health guidance [18] states that “to give
valid consent, the person needs to understand the nat-
ure and purpose of the procedure. Any misrepresenta-
tion of these elements will invalidate consent”. When
considering what information to provide, the Act states
that the researcher should “try to ensure that the person
is able to make an informed judgement on whether to
give or withhold consent”. To this end, a detailed infor-
mation sheet has been developed for the potential
research participants who will be asked to participate in
the trial. The information sheet provides contact details
for obtaining further information, details on the planned
research, rights to non−participation, how their details
were selected and how data will be stored according to
the principles of the Data Protection Act [20].
Timing of consent
Department of Health guidance [18] states that “it is
good practice where possible to seek the person’s con-
sent to the proposed procedure well in advance, when
there is time to respond to the person’s questions and
provide adequate information”. Consequently hospital
nursing staff will provide the patient with the informa-
tion sheets prior to discharge which they can review at
their leisure over a period of no less than 24 hours
before a specialist COPD clinician visits them to under-
take their first clinical assessment, at which time the
trial will be explained and their consent to participate in
the trial will be sought.
Form of consent
Although completion of a consent form is in most cases
not a legal requirement it is recognized as good practice,
so written consent will always be obtained. Copies of the
consent forms to be used are included in the
appendices.
Patient Population and Recruitment
Inclusion criteria
• Open to male and female adult participants (> age
16);
• Being discharged from the acute care Trust and
diagnosed with COPD;
• Between 1 and 3 previous admissions (including
the current admission) in the previous 12 months
according to the hospital discharge abstract from
the current date of discharge where COPD is the
primary or secondary documented reason for
hospitalisation
• Patient has consented to be included in the case-
load of the Community COPD Service;
• Willing to use Tele-health technology as part of
their discharge plan;
• Able to communicate in English and read English
(a requirement of the technology); and
• Have a telephone landline and a viable telecommu-
nications network with no more than three internal
telephone extensions.
Exclusion criteria
• Prior/current involvement in another tele-health
initiative;
• Cognitive impairment to the extent that it impedes
ability to participate;
• Other significant impairments which will restrict
ability to participate;
• No telephone landline;
• Unwilling to use Tele-health technology;
• Existence of co-morbidities which require on-going
intervention from other community nursing services;
• More than three hospital admissions within twelve
months of the date of discharge for which COPD is
the primary diagnosis; and
• Patient unable or unwilling to provide written or
oral informed consent.
Basic details (age, gender, prior hospitalisations for
COPD) will be collected for all eligible patients to allow
completion of a CONSORT [21] flow chart as depicted
in Figure 1.
Whilst still in hospital, either the COPD or ward staff
(depending upon the referral route) will provide the
patient with a leaflet about the Community COPD
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Service, a patient information sheet and a copy of the
research consent form prior to their discharge. The
patient will be made aware that the clinicians from the
Community COPD Service will provide them with more
information about the research on their first visit (day
after patient’s discharge from the hospital). On this first
home visit, a clinician from the Community COPD Ser-
vice, who has undertaken Good Clinical Practice training
and is therefore qualified to seek patient consent to parti-
cipate in the trial, will confirm that patients meet all the
Adults discharged from 
hospital with COPD as 
primary/secondary reason for 
admission
PCT Staff apply 
eligibility criteria
Invited to 
participate
Declined participation 
(n=?)
Randomised 
(n=60)
SDS 
(n=30)
T-SDS 
(n=30)
Postal questionnaire 
6 months after completing 
SDS/T-SDS service
• Health care resource use
•Quality of life
Excluded:
•Current/prior participation (n=?)
•Cognitive impairment (n=?)
•Lack of landline (n=?)
•Unwilling to use technology (n=?)
•Co-morbidities (n=?)
•>3 admissions in 12 months (n=?)
•GP identifies pt as unsuitable (n=?)
Figure 1 Graphical depiction of the interventions.
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inclusion criteria to participate in the trial; will explain
the study if any additional information is requested; and
seek consent to participate in the trial. They will then
aim to recruit patients initially to the service and, sec-
ondly, to the trial. Should a patient not wish to partici-
pate in the research they can still receive the standard
Community COPD Service but will not be included in
the study. As identified in the exclusion criteria, any
patient unwilling to consider the technology as part of
their care plan will be excluded from the trial although
they can receive the standard Community COPD Service.
Randomisation
Consented patients will be randomized using a web-
based system developed by the University of Sheffield
Clinical Trials Research Unit. A simple randomisation
sequence will be used to allocate patients to either the
standard Community COPD Service or the Tele-health
supported Community COPD Service. It is impossible to
blind patients or clinical staff to the trial arm, but
research staff will be blind to the allocation. Administra-
tion staff at the Community COPD Service will use the
web-system to identify the allocation for the next patient
who consents to participate in the trial, but at this stage
the clinician seeking consent from the patients will be
blinded to the allocation to prevent any bias in recruit-
ment. Once consent has been received, the clinician will
contact the administration centre to obtain the alloca-
tion. At this point they will inform the patient of the allo-
cation and tell them whether they will receive the tele-
health supported or standard community COPD service.
Intervention
The two care pathways and associated research inter-
ventions are depicted graphically in Figure 2. All visits
and telephone calls described below will be undertaken
by clinical staff of the Community COPD Service team.
Tele-health Intervention
Patients recruited to the Tele-health supported Commu-
nity COPD Service will be taught how to use the tech-
nology to aid monitoring of their condition. The patient
will be required to enter information into the tele-health
equipment on a daily basis to monitor their condition.
Data provided to the system will be recorded on the
web server so patient compliance with using the equip-
ment can be assessed. If the patient fails to enter infor-
mation into the equipment for three continuous days
the system generates an alert on the web server which is
acted upon by the COPD team.
Usual Care Group
Patients recruited to the standard Community COPD
Service will not receive the technology but will have six
visits with specialist COPD clinicians from the Commu-
nity COPD Service as described in Figure 2.
Data collection tools
St. Georges Respiratory Questionnaire
Patients will be asked to complete the St. Georges
Respiratory Questionnaire score upon admission to
either the Tele-health supported or standard Community
Time Line
Standard COPD 
Service
(Control)
Tele-health 
Supported COPD 
Service
First home visit 
after hospital 
discharge 
(Baseline (time 0)
a      b   c
d         e
a     b      c   g
d         e        
Randomisation
1 day l
2 days a    c
4 days f       c      g
i
14 days f       h  
j
m
6 weeks f       h  
j
8 weeks f        h        c
e     j       k     
f      h      c  
e       j       k     n
8 months Measurement of outcomes  
a
b Social assessment (part of standard clinical intervention)
c Patient education / self management session (duration unspecified) - (part of standard clinical intervention)
d Clinician to seek written consent from patient (see appendix 2 for copy of consent form)
e St. George’s Respiratory Questionnaire on health status and quality of life completed by patient
f  Clinical assessment - (part of standard clinical intervention)
g Patient self-management plan put in place - (part of standard clinical intervention)
h Patient self-management assessed - (part of standard clinical intervention)
i Self-report diary for health resource use explained to the patient by the clinician and implemented (see appendices 4a, 
b and c for diary sheets)
j Review of self-diary resource use by research staff
k Patient discharged from the clinical programme if determined stable by clinical staff - (part of standard clinical intervention)
l Tele-health equipment installed in patient’s home by Local Authority installer and training provided
m Tele-health alert parameters reviewed and adjusted remotely by admin/clerical staff as directed by clinicians
n Tele-health  service satisfaction questionnaire completed by patient
Clinical assessment of stability and coping with discharge by 
COPD clinicians (part of standard clinical intervention)
Figure 2 CONSORT Flow Chart.
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COPD Service, on discharge from the service and six
months after discharge from the service. This question-
naire is a validated and widely-used instrument which
measures health impairment in patients with COPD on a
scale of 0 to 100 (greatest impairment). This scale is
responsive to change with a minimum important differ-
ence (MID) of 4.
Diaries
Patients recruited to the Usual Care Group will track
their use of health services to assist in the management
of their COPD by means of a self-reported questionnaire
whilst on the eight week programme and for the subse-
quent six months. Patients will record whether they
have contacted a health service provider because they
had concerns about their COPD, who they contacted,
why they contacted them and what happened as a result
(telephone consultation, visit). The diaries will also be
used to capture EQ5 D information on problems with
mobility, self-care, usual activities, pain/discomfort and
anxiety/depression.
Patients on the Tele-health supported Community
COPD Service will be asked to answer the same ques-
tions as part of their routine use of the technology.
Tele-health service questionnaire
Patients on the Tele-health supported Community
COPD Service will be asked to complete a questionnaire
on discharge from the service. The questionnaire will
ascertain their opinions about the technology, the instal-
lation process, training, use of the equipment, availabil-
ity of support and removal of the equipment from their
home.
Research Governance
The trial will be conducted in accordance with MRC
Guidelines [22,23]. The acute trust will act as the spon-
sor of this project.
A Trial Management Committee will be established
and will consist of the Principal Investigator, Research
Project Manager, research staff, PCT Operations Man-
ager, Operational Project Manager and the clinicians.
Meetings of this team will be held monthly during the
three month pilot.
A Data Monitoring Committee will meet towards the
end of the pilot to review adherence to enrolment, ran-
domisation strategy and examine the trial data. This
committee will consist of an independent statistician, an
independent trialist, the Principal Investigator and
Research Project Manager.
Patient and Public Involvement (PPI)
In the acute trust, a local group founded on the princi-
ples of INVOLVE [24], known as the Consumers
Research Advisory Group (CRAG), meet three to four
times per year, and their key role is undertaking reviews
of proposed projects. This generally involves reading
research proposals, and other project literature, and pro-
viding feedback on any areas which the researcher has
requested, or those the group feel are in need of revision
or clarification. A copy of the protocol for this pilot has
been shared with CRAG and will be discussed at their
next meeting. Feedback from the group will be incorpo-
rated into the design and conduct of the subsequent
research phases. The protocol for the definitive trial will
again be shared with this group as will the findings of
the research.
Discussion
The high local prevalence of COPD contributed to the
£2.2 million cost of related admissions billed to the local
health service between April 2006 and March 2007 [16].
Consequently, the acute trust, the Commissioners and
PCT have all recognized the urgent need to support
patients and minimize unnecessary hospital admissions
and emergency room visits. This initiative is one of the
approaches being considered to address this goal.
Whilst the need to improve care delivery modalities
and reduce reliance on the acute sector is recognized, in
reality, the shift to the primary sector is proving more
difficult to enact than initially anticipated. This project
is posing a number of challenges for the PCT undertak-
ing the implementation of the tele-health supported
Community COPD Service.
In developing their project plan for implementation of
the tele-health supported service, the PCT realized that
they did not have the resources and expertise to under-
take the installation of equipment into patient’s homes.
Within the city, the Local Authority had established a
service providing a 24-hour, 365 day a year emergency
response service for approximately 7,000 residents of
the Borough, with approximately 4,700 service users
linked to the service using Individual Alarm Units and
the remainder in Local Authority and Housing Associa-
tion accommodation linked by hard-wired intercom sys-
tems. Clearly this centre had experience in installing
comparable technology into people’s homes, so the PCT
created a partnership with the Local Authority, tasking
them with the installation of the tele-health equipment
within 72 hours of hospital discharge.
This horizontal integration is an innovative model
which has needed detailed planning and a great deal of
collaboration. Both partners have provided extensive
support to the project, developing detailed flowcharts to
identify key activities, responsibilities and timings to
ensure all elements of the project remain on track;
developing training materials for staff and patients;
shared forms to capture data required by all partners
and shared spreadsheets to track patient-specific data to
ensure there are no gaps in service delivery and
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technology-related data to ensure that its location and
condition (installed and in use/in stock/unavailable -
awaiting cleaning) are always known. Methods to
address requirements for routine portable appliance
(PAT) testing to meet the Electricity at Work Regula-
tions [25], infection control, confidentiality of patient
records and the safe installation of the technology have
all needed to be addressed.
Tele-health may offer a way to provide care and
encourage self-management of the condition for early
stage COPD patients within the primary care sector,
and this will be evaluated in the planned RCT. However,
preparation for this RCT has provided evidence of speci-
fic challenges in implementing tele-health supported
services which may require quite innovative solutions.
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